Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients.

Maria Martinez-Urbistondo Alberto Mora-Vargas Esther Expósito-PalomoRaquel CastejónMaría-Jesús Citores Silvia Rosado Carmen de Mendoza Isolina Baños Ana Fernández Cruz Lidia Daimiel Ruiz Rodrigo San-Cristóbal Juan-Antonio Vargas-Núñez José Alfredo Martínez Hernández

Published in: Mediators of inflammation (2020)

IL-6 together with other inflammatory biomarkers accompanied poor clinical and metabolic outcomes in COVID-19-infected patients. IL-6 may result in a suitable proxy to individually categorise patients in order to manage this infectious pandemic.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
oxidative stress
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
metabolic syndrome
skeletal muscle
weight loss
glycemic control